IV equipment market seen reaching $22.3 billion by 2033

Persistence Market Research projects the global IV equipment market will rise from $15.8 billion in 2026 to $22.3 billion by 2033 as hospitals, home care providers and specialty facilities increase use of infusion pumps, catheters and related devices. The report points to smart infusion technology, chronic disease treatment and expanding healthcare infrastructure as the main growth drivers.

Why it matters: - IV equipment is core to delivering fluids, medications, blood products and nutritional support safely. - Demand is rising as hospitals handle more admissions, more surgeries and more chronic disease care. - Smart infusion systems and monitoring tools are changing how providers manage accuracy, safety and workflow.

What happened: - Persistence Market Research said the global IV equipment market is expected to grow from US$15.8 billion in 2026 to US$22.3 billion by 2033. - The forecast implies a 5.1% CAGR from 2026 to 2033. - The report identifies infusion pumps as the leading product segment. - The report says hospitals remain the largest end-user segment. - North America leads the market. - The report includes sample, customization and purchase links: Get a free sample report, request report customization and buy the full report.

The details: - The product mix includes infusion pumps, IV catheters, IV sets, accessories and related intravenous administration devices. - Infusion pumps lead because they allow controlled medication delivery, help reduce dosing errors and improve patient monitoring. - Disposable IV products are gaining traction as providers focus on infection prevention and patient safety. - Hospitals account for the biggest share because of patient admissions, emergency care needs and surgery volumes. - Ambulatory surgical centers, specialty clinics and home healthcare providers are using more advanced IV equipment. - Smart infusion technologies are improving medication accuracy, patient safety and treatment efficiency. - Chronic conditions such as cancer, cardiovascular disease, infectious disease and metabolic disorders are increasing long-term IV use. - Portable IV devices are seeing more demand as home healthcare expands.

Between the lines: - North America’s lead reflects advanced healthcare infrastructure, higher healthcare spending and faster adoption of new medical technology. - Asia Pacific is set for strong growth as healthcare systems expand, spending rises and access to advanced treatment improves. - High upfront costs, maintenance, software upgrades and calibration remain barriers for advanced infusion systems. - Medical device regulation slows commercialization because approvals require testing and documentation. - Connected devices also face device malfunction and cybersecurity concerns.

What's next: - Emerging economies are likely to create new demand as hospitals and healthcare networks expand. - Manufacturers are expected to push more portable, user-friendly and remote-care-ready IV products. - More digital technology, artificial intelligence and remote monitoring could broaden use cases and improve efficiency. - Continued home healthcare adoption should open another growth path for the market.

The bottom line: - IV equipment is moving from a hospital utility to a more connected, more portable and more technology-driven care category, with steady growth projected through 2033.